이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Training Non-Anesthesia Personnel to Perform Nerve Blocks in Microgravity (Block-aid)

2026년 9월 25일 업데이트: Jon Bailey, Nova Scotia Health Authority

Training Non-Anesthesia Personnel to Perform Nerve Blocks in Microgravity: A Prospective Cohort Study

Space exploration is rapidly progressing with multiple upcoming missions planned to the moon and International Space Station, and projected missions to Mars in the early 2030s. Multiple types of injuries and surgical emergencies are possible during space travel. With the rapidly increasing number of travelers, healthcare providers need to refine our plans for responding to surgical emergencies in space.

It may not be possible to return injured crew members to earth for medical treatment depending on distance from earth and the severity of the injury. Furthermore, the casualty's physiologic changes in microgravity, and logistical limitations of repatriation make addressing medical emergencies challenging. Pain medications and general anesthesia have side effects that can impact safety in space and have worse side effect profiles when compared to on earth.

Regional anesthesia, injecting local anesthetic near to a nerve(s) to create a large area of numbness on the body, has been used for many years for pain management and to allow for surgery in remote settings on earth. Military personnel have used these techniques to provide effective pain control for evacuating wounded soldiers, while maintaining their cognition. For these reasons, regional anesthesia (aka 'nerve block') has been promoted as a viable solution for injured astronauts.

Our team has demonstrated that simple nerve blocks are possible in simulated microgravity among trained anesthesia providers. Recognizing that non-physician medical technicians may be integral to future space missions, this study aims to ascertain the feasibility of training such personnel to perform simple nerve blocks in microgravity.

연구 개요

상태

완전한

정황

개입 / 치료

상세 설명

With the burgeoning human presence in space, the need to prepare for medical emergencies in microgravity environments becomes increasingly critical. Space is an inherently hazardous environment, with 21 known fatalities. Most injuries occur during lift off or re-entry, but in-flight incidents have also been reported, including fires, blunt injuries, vehicular collisions, and loss of environmental controls. Extraction times vary significantly, with the potential for hours in low-earth orbit (LEO), days from the Moon, and months from Mars. In this case or during more distant space exploration, damage control procedures may be necessary.

If astronauts are injured, physiologic and logistic complexities necessitate a different approach from hospital-based care on Earth. In addition, due to ergonomic challenges of microgravity. Systemic pain medication is not optimal in that it can cause sedation, confusion, and even delirium. This could compromise safety for the crew given the small numbers of personnel who play critical roles. If a surgical intervention was required, general anesthesia is problematic for multiple reasons.

The benefits of regional anesthesia (nerve blocks) have been recognized in remote settings, including regions with fewer resources and trained providers. Regional anesthesia limits airway management, ventilation, and hemodynamic changes. The equipment is portable, offers stable hemodynamics, effective analgesia, minimal need for supplemental oxygen, and improved alertness. As each crew member's role is pivotal for mission success, regional anesthesia ensures their cognitive participation. Our group has shown that nerve blocks are feasible in a simulated microgravity environment when performed by anesthesiologists and anesthesia residents.

In specialized teams such as astronauts, rigorously trained for space exploration, there might not be the depth of personnel to allow physicians on crews. At the current time, most missions have a single Crew Medical Officer (CMO) who is usually not a physician. Space travel with its associated communication and logistical delays further emphasizes the need for such medical training so they can act without real-time guidance.

Aim Recognizing that non-physician medical technicians may be integral to future space missions, our study aims to ascertain the feasibility of training such personnel to perform simple nerve blocks in microgravity.

Hypothesis The investigators hypothesize that despite training about nerve block mechanics and ultrasound imaging, non-physician personnel have worse accuracy, time to injection, and ease of needle placement in a simulated microgravity environment than compared to normal gravity conditions. Furthermore, the investigators hypothesize that accuracy, time to injection, and ease of needle placement will be inferior to anesthesia providers in a simulated microgravity environment.

Methods This will be a prospective cohort study using within- and between-subjects comparisons. This study will assess the ease and success of ultrasound-guided injections ("nerve blocks") by non-anesthesia personnel comparing normal gravity to microgravity conditions using a meat model. Secondly, the ease and success rate of non-anesthesia participants will be compared to anesthesia participants.

Recruitment and Allocation The investigators will recruit 20 non-anesthesia military personnel and 5 anesthesia providers who are trained scuba divers. Inclusion criteria for the non-anesthesia group would be adult (age >18 years) certified scuba divers and those who have not had prior nerve block technique training. Inclusion criteria for the anesthesia group are that they are staff anesthesiologists or senior residents and certified scuba divers since nerve block training is part of basic anesthesia training.

Training session Recruited participants would be given a 4-hour training session on ultrasound imaging theory and practical optimization, needle visualization and control, basics of local anesthetics, basic sono-anatomy, and complications of nerve blocks. This session will be developed and led by regional anesthesia fellowship trained team members. There will be opportunities to practice image acquisition and needle placement with feedback. This session will take place the day before the study.

Meat model creation All injections will use a meat model. This meat model using beef muscle, beef tendon, and ballistics gel has been previously validated for accessing accuracy of US-guided injections.

Gravity conditions In the normal gravity condition, participants will be in a seated position with the meat model positioned in the chest wall of a mannikin, supported on a table. The ultrasound, phone, and dive case will be the same as in the microgravity condition. Participants will use hand signals to communicate with their block assistant since verbal communication will not be possible underwater.

In the microgravity condition, the participants will be scuba diving in a pool. The mannikin will be secured to a table at the bottom of the pool and they will empty their buoyancy control device (causing them to sink), effectively removing the added complexity of buoyancy control. An investigator will assist each participant with the block by positioning the meat model in the mannikin, passing equipment, and injecting the dye through a syringe once they are signalled to do so. However, the investigator will not give the participant guidance on the accuracy of the needle position or the quality of their ultrasound image.

Statistical analysis and power calculation Demographics will be collected (age, gender, prior medical training, experience with nerve blocks) and reported in aggregate for the purposes of external validity and generalizability. Outcomes will be compared between normal gravity and microgravity for non-anesthesia participants (within subjects, paired data). Outcomes will also be compared between anesthesia and non-anesthesia participants (between subjects, independent data).

Data will be analyzed using generalized estimating equations to adjust for the clustered nature of the data (i.e., blocks nested within participants). For binary outcomes (success vs. failure), a binomial outcome with a logit link will be used. For numerical outcomes, a normal distribution will be assumed, though loglinear models for skewed distributions will also be explored if they fit the data better.

Power analyses adjust sample sizes for the clustered design using the design effect method described by Bland (2004). Moreover, the design assumes 14 blocks per participant. The first a-priori power analysis is for comparing normal gravity and microgravity for non-anesthesia participants with the outcome of success vs. failure. Assuming a one-tailed alpha of 0.05, power of 80%, a normal gravity success rate of 90% and a microgravity success rate of 70%, and an intraclass correlation of 0.10, a total of 19 non-anesthesia participants will be required.

The second a-priori power analysis is for comparing normal gravity and microgravity for non-anesthesia participants for time to block, which has been used as a measure of ease in learning curve studies. Assuming a one-tailed alpha of 0.05, power of 80%, a mean difference of 12 seconds, a standard deviation of 23 seconds (based on data from our prior study), and an intraclass correlation of 0.10, a total of 15 participants will be needed.

연구 유형

중재적

등록 (실제)

30

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Nova Scotia
      • Dartmouth, Nova Scotia, 캐나다, B2Y 4K9
        • Survival Systems Training Limited

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria for the non-anesthesia group:

  • adult (age >18 years)
  • certified scuba divers
  • no prior nerve block technique training.

Inclusion criteria for the anesthesia group:

  • staff anesthesiologists or senior residents
  • certified scuba divers

Exclusion Criteria:

  • active ear nose and throat conditions that prevent ear equalization
  • neuromotor conditions interfering with fine motor skills
  • pregnancy
  • inability to consent

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Simulated Microgravity

In the microgravity condition, the participants will be scuba diving in a pool. The mannikin will be secured to a table at the bottom of the pool and they will empty their buoyancy control device (causing them to sink), effectively removing the added complexity of buoyancy control. An investigator will assist each participant with the block by positioning the meat model in the mannikin, passing equipment, and injecting the dye through a syringe once they are signaled to do so. However, the investigator will not give the participant guidance on the accuracy of the needle position or the quality of their ultrasound image.

Neutral buoyancy underwater

활성 비교기: Normal gravity

In the normal gravity condition, participants will be in a seated position with the meat model positioned in the chest wall of a mannikin, supported on a table. Participants will use a high-frequency (4-13 MHz) linear transducer and a 22G 50 mm echogenic needle to inject the meat model with 1-2 ml of water mixed with blue food coloring. The ultrasound, phone, and dive case will be the same as in the microgravity condition. Participants will use hand signals to communicate with their block assistant since verbal communication will not be possible underwater.

Same procedure on land

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Injection success
기간: 3.5 minutes

Post-injection the models will be stored in a refrigerator for at least 24 hours to dry and allow the dye to settle. Two blinded investigators will dissect the models and score them. A successful nerve block will be defined as visible blue dye staining the outside of the beef tendon without evidence of injection inside of the tendon. The presence of primarily intraneural or intramuscular staining will be considered a failed block.

3.5 minutes

2차 결과 측정

결과 측정
측정값 설명
기간
Time to injection
기간: 3.5 minutes

Defined as the time from the transducer first touching the nerve block model to when the needle was removed from the model.

Time was censored at 3.5 minutes, such as the participants were signalled to stop at the maximum time and the attempt was recorded as incomplete (due to time constraints).

3.5 minutes
Number of needle passes
기간: 3.5 minutes

Any needle passes that appeared to contact the tendon (simulated nerve), judged by noticeable movement of the tendon, were be recorded by the investigator. The number of needle passes were also recorded, judged as the number of times the needle was withdrawn and repositioned (adjustments in trajectory were not counted).

3.5 minutes
Ease of ultrasound image acquisition
기간: 5 minutes

Scored immediately after each block in both conditions using a 5-point Likert scale (1 = very difficult, 2 = difficult, 3 = neutral, 4 = easy, 5 = very easy).

5 minutes
Ease of needle placement
기간: 5 minutes

Scored immediately after each block in both conditions using a 5-point Likert scale (1 = very difficult, 2 = difficult, 3 = neutral, 4 = easy, 5 = very easy).

5 minutes
Intraneural injection
기간: 3.5 minutes

Post-injection the models were be stored in a refrigerator for at least 24 hours to dry and allow the dye to settle. Two blinded investigators dissected the models to score the position of the dye. The presence of dye within the tendon will be considered an "intraneural" injection.

3.5 minutes

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 3월 20일

기본 완료 (실제)

2026년 3월 29일

연구 완료 (실제)

2026년 3월 29일

연구 등록 날짜

최초 제출

2026년 9월 17일

QC 기준을 충족하는 최초 제출

2026년 9월 25일

처음 게시됨 (실제)

2026년 9월 30일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 30일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 25일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • REB # 2024-7417

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

IPD 계획 설명

Ability to share would be based on ethical and Canadian Armed Forces approval on a case by case basis.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .